The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen

Medical Principles and Practice

Volumn 19, Issue 3, 2010, Pages 222-227

  Kazerooni, Talieh ^a   Ghaffarpasand, Fariborz ^c   Mosalaei, Ahmad ^b   Kazerooni, Yasaman ^a  

^a Department of Obstetrics and Gynecology ^*  (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Endometrial atrophy; Endometrial biopsy; Tamoxifen; Transvaginal ultrasonography

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOMETRIUM; ENDOMETRIUM ATROPHY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; ENDOMETRIUM THICKNESS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PREVALENCE; TRANSVAGINAL ECHOGRAPHY; VAGINA BLEEDING;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SOCIOECONOMIC FACTORS; TAMOXIFEN; VAGINA;

EID: 77950543944     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000285296     Document Type: Article

References (24)

1. Osborne CK: Tamoxifen in the treatment of breast cancer. N Engl J Med 1998; 339: 1609-1618.
2. Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begovic M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher L, Oishi RH: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999; 353: 1993-2000. (Pubitemid 29271743)
3. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90: 1371-1388. (Pubitemid 28439961)
4. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML: High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 1993; 11: 485-490. (Pubitemid 23071046)
5. Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L: Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 1990; 163: 119-123. (Pubitemid 20253073)
6. Granberg S, Wikland M, Karlsson B, Norstrom A, Friberg LG: Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol 1991; 164: 47-52.
7. Andolf E, Dahlander K, Aspenberg P: Ultrasonic thickness of the endometrium correlated to body weight in asymptomatic postmenopausal women. Obstet Gynecol 1993; 82: 936-940. (Pubitemid 23347990)
8. Exacoustos C, Zupi E, Cangi B, Chiaretti M, Arduini D, Romanini C: Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Ultrasound Obstet Gynecol 1995; 6: 435-442.
9. Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO, Campbell S: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet 1994; 343: 1318-1321. (Pubitemid 24162571)
10. Hendrickson MR, Kempson RL: Endometrial hyperplasia, metaplasia and carcinoma; in Fox H (ed): Obstetrical and Gynaecological Pathology. Edinburgh, Churchill Livingstone, 1987, pp 354-362.
11. Stovall TG, Ling FW, Morgan PL: A prospective, randomized comparison of the pipelle endometrial sampling device with the Novak curette. Am J Obstet Gynecol 1991; 165: 1287-1289.
12. Saidi MH, Sadler RK, Theis VD, Akright BD, Farhart SA, Villanueva GR: Comparison of sonography, sonohysterography, and hysteroscopy for evaluation of abnormal uterine bleeding. J Ultrasound Med 1997; 16: 587-591. (Pubitemid 27494578)
13. O'Connell LP, Fries MH, Zeringue E, Brehm W: Triage of abnormal postmenopausal bleeding: a comparison of endometrial biopsy and transvaginal sonohysterography versus fractional curettage with hysteroscopy. Am J Obstet Gynecol 1998; 178: 956-961. (Pubitemid 28247169)
14. Timmerman D, Deprest J, Bourne T, Van den Berghe I, Collins WP, Vergote I: A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 1998; 179: 62-70. (Pubitemid 28394474)
15. Laifer-Narin S, Ragavendra N, Parmenter EK, Grant EG: False-normal appearance of the endometrium on conventional transvaginal sonography: comparison with saline hysterosonography. AJR Am J Roentgenol 2002; 178: 129-133. (Pubitemid 34016387)
16. Love CDB, Muir BB, Scrimgeour JB, Leonard RCF, Dillon P, Dixon JM: Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 1999; 17: 2050-2054. (Pubitemid 29318834)
17. Gerber B, Krause A, Muller H, Reimer T, Kulz T, Makovitzky J, Kundt G, Friese K: Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol 2000; 18: 3464-3470.
18. Barakat RR: Screening for endometrial cancer in patients receiving tamoxifen for breast cancer. J Clin Oncol 1999; 17: 1967-1968. (Pubitemid 29318822)
19. Neven P, Vergote I: Tamoxifen, screening and new oestrogen receptor modulators. Best Prac Res Clin Obstet Gynaecol 2001; 15: 365-380. (Pubitemid 32631470)
20. Machado F, Rodriguez JR, Leon JP, Rodriguez JR, Parrilla JJ, Abad L: Tamoxifen and endometrial cancer: is screening necessary? A review of the literature. Eur J Gynaecol Oncol 2005; 26: 257-265. (Pubitemid 40874036)
21. Lucente VR, Navarro NF, Dupree WB: The predictive value of endometrial thickness in patients receiving tamoxifen. J Pelvic Surg 2000; 6: 16-19.
22. Achiron R, Lipitz S, Sivan E, Goldenberg M, Horovitz A, Frenkel Y, Mashiach S: Changes mimicking endometrial neoplasia in tamoxifen- treated women with breast cancer: a transvaginal Doppler study. Ultrasound Obstet Gynecol 1995; 6: 116-120.
23. American College of Obstetricians and Gynaecologists: Tamoxifen and endometrial cancer. ACOG Committee Opinion 232. Washington, American College of Obstetricians and Gynaecologists, 2000.
24. Bourne TH, Lawton F, Leather A, Granberg S, Campbell S, Collins WP: Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps. Ultrasound Obstet Gynecol 1994; 4: 73-75.